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        Within most human and mouse cancers there is 
a signifi  cant macrophage population, attracted 
to the tumor microenvironment by cytokines 
and chemokines such as CSF-1 and CCL2 (  1, 2  ). 
Macrophages are plastic cells; their phenotype 
depends on their anatomical location and the 
physiological or pathological context. Classi-
cally activated macrophages (also called M1) 
and   “  alternatively  ”   activated macrophages (M2) 
represent two extremes in the spectrum of the 
macrophage phenotype ( 3  ). Tumor-associated 
macrophages (TAMs) closely resemble   “  alter-
native  ”   (M2) macrophages (  4  ). M2 macrophages 
produce high amounts of IL-10 but not IL-12, 
express scavenger receptors, and exhibit anti-
infl  ammatory and tissue repair functions (  5  ). 
In contrast, M1 macrophages, activated by micro-
bial products or IFN-    , produce large amounts of 
proinfl  ammatory cytokines, express high levels 
of MHC molecules, and are potent killers of 
pathogens and tumor cells (  3  ). Despite their 
intrinsic antitumor potential as both tumoricidal 
cells and the major antigen-presenting cells pre-
sent in tumors, ablation of macrophage function 
or their infi  ltration into experimental tumors 
inhibits cancer growth and metastasis (  1, 6, 7  ). 
Due to the large TAM population in many tu-
mors, an attractive therapeutic approach would 
be to increase their tumoricidal activity and at-
tempt to promote antitumor immunity. 
  Recent studies in mouse models of colon 
and liver cancer have defi  ned an important role 
for NF-    B activation in driving cancer-associ-
ated infl  ammation (  8, 9  ). Our data describe 
an additional role for NF-    B in maintaining 
the immunosuppressive TAM phenotype. We 
have previously shown that malignant epithe-
lial cells polarize macrophages to an M2-like 
phenotype (  10, 11  ). Here, we show that malig-
nant epithelial cells drive NF-    B activation in 
TAMs in a way that maintains their immuno-
suppressive phenotype. 
  The experiments described here are based 
on the hypothesis that NF-    B signaling is the 
central mechanism that maintains the alterna-
tive phenotype of TAMs. To investigate this 
we have used two diff  erent approaches to block 
NF-    B activity specifi  cally in macrophages, both 
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and elevated inducible nitric oxide (NO) synthase (NOS2) 
expression (  Fig. 2 B   and Fig. S1 C). Furthermore, increased 
NOS2 expression correlated with an increase in NO levels in 
the co-culture supernatant (  Fig. 2 A   and Fig. S1 B). These 
data suggested that inhibition of IKK     signaling in BMDMs 
co-cultured with ID8 cells, and TAMs isolated from estab-
lished tumors, switched macrophages from an M2 to a   “  clas-
sically  ”   activated M1 phenotype. 
of which target I    B kinase (IKK)    , the major activator of 
NF-    B. Mouse bone marrow  –  derived macrophages (BMDMs) 
were infected with a recombinant adenovirus expressing a 
dominant-negative inhibitor of IKK     (Adv-IKK      DN  ). IKK     
expression was also targeted in mice harboring a   “  fl  oxed  ”   
  Ikk       allele (IKK      f/f  ) with adenovirus expressing Cre recombi-
nase (Adv-Cre) to generate IKK    -null macrophages (IKK           ) 
(  12  ). Our data show that targeting IKK     activity in BMDMs 
co-cultured with malignant tumor cells or TAMs isolated from 
established tumors reverses their tumor-promoting activity and 
promotes an antitumor M1 phenotype. 
    RESULTS AND DISCUSSION   
  We previously showed that co-culture of BMDMs with human 
and mouse ovarian cancer cells led to increased tumor cell 
invasion (  10, 11  ). In the fi  rst series of experiments described 
here, we investigated the macrophage signaling pathways 
that drive tumor cell invasion using co-cultures of BMDMs 
and syngeneic ID8 mouse ovarian cancer cells. Our fi  rst ob-
servation was that co-culture with macrophages defi  cient 
in MyD88 and IL-1R but not Toll-like receptor (TLR)2 or 
TLR4 inhibited, rather than increased, invasiveness of tumor 
cells in vitro (  Fig. 1 A  ).   Downstream of IL-1R and MyD88, 
we found that the ability of macrophages to enhance tumor 
cell invasiveness was dependent on NF-    B activation. Spe-
cifi  c inhibition of IKK     signaling and NF-    B activation by 
expression of IKK      DN   or targeted deletion of IKK     (IKK           ) in 
BMDMs prevented these cells from enhancing tumor cell in-
vasiveness in vitro (  Fig. 1 A   and Fig. S1 A, which is available 
at http://www.jem.org/cgi/content/full/jem.20080108/DC1). 
We also isolated CD11b  +   TAMs from ID8 tumor-bearing 
mice and infected them in vitro with Adv-IKK      DN   before 
co-culture with ID8 cells. As with BMDMs, inhibition of 
IKK     activity in TAMs also prevented tumor cell invasion 
(  Fig. 1 A  ). 
  Previous literature has suggested that the mechanism by 
which inhibition of NF-    B prevented macrophage-induced 
tumor cell invasion might be due to decreased production 
of chemotactic factors by macrophages (  8  ). But in fact we 
found that co-culture with IKK   -targeted BMDMs or TAMs 
isolated from established tumors increased tumor cell apop-
tosis, as measured by caspase 3/7 activation (  Fig. 1 B  ). In 
addition, inhibition of IKK     activity in BMDMs or TAMs 
enhanced macrophage-mediated tumoricidal activity in vitro 
(  Fig. 1 C  ). 
  We have previously shown that co-culture with ID8 cells 
polarizes macrophages to an M2-like phenotype: IL-10  high  , 
IL-12  low  , increased scavenger receptor expression, and TNF-
      high   (  10, 11  ). NF-    B inhibition by expression of IKK      DN   or 
targeted deletion of IKK     (IKK           ) in BMDMs and TAMs 
isolated from ID8 tumors reduced production of IL-10 and 
TNF-     upon co-culture with tumor cells in vitro (  Fig. 2 A   
and Fig. S1 B); however, IKK     inhibition increased production 
of the antitumor cytokine IL-12 (  Fig. 2 A   and Fig. S1 B).   
The IL-12  high   IL-10  low   phenotype of IKK    -targeted macro-
phages was associated with decreased expression of arginase-1 
    Figure 1.         IKK     inhibition increases macrophage tumoricidal activ-
ity.   (A) WT, MyD88     /   ,  TLR-2    /   ,  and  TLR-4    /     or mock, IKK    DN   or  IKK   f/f , 
and IKK          BMDMs were co-cultured with ID8-Luc in a modifi  ed Boyden 
chamber without direct cell  –  cell contact for 72 h. In addition, CD11b  + -
selected TAMs from the ascites of ID8 tumor  –  bearing mice were mock 
(TAM  mock  ) or IKK    DN   infected  (TAM DN  ). Invasion of ID8-Luc cells was as-
sessed by luciferase activity in the lower part of the chamber. Macro-
phages deleted in MyD88, IL-1R, or IKK     signifi  cantly reduce ID8-Luc 
invasion (P   <   0.01;   t   test with Welch  ’  s correction). Data are represented as 
mean   ±   SEM of   n   = 6. Representative data are shown from at least three 
independent experiments. (B) ID8 cells were co-cultured with IKK   -tar-
geted BMDMs or TAMs and respective control cells. Fluorescence caspase 
3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKK    DN   and 
IKK          BMDMs or TAMs expressing IKK    DN   (TAM DN )  signifi  cantly increases 
caspase 3/7 activity in ID8 cells (P   <   0.01;   t   test  with  Welch ’ s  correction). 
Data are represented as mean   ±   SD of   n   = 6. Representative data are 
shown from at least three independent experiments. (C) [  111 In]oxine  re-
lease assay after a 24-h co-culture of   111  In-labeled ID8 cells with mock, 
IKK    DN ,  TAM DN   or IKK    f/f  , and IKK          macrophages.   111  In-release in cell-free 
culture supernatants was measured after 24 h with a scintillation counter. 
IKK    -targeted macrophages promote increased cytotoxicity. Data are 
represented as mean of   n   = 3. Representative data are shown from at 
least three independent experiments.     JEM VOL. 205, June 9, 2008  1263
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  As Stat1 is an essential transcription factor for IL-12, MHC 
class II, and NOS2 expression (  13  ), we analyzed Stat1 activa-
tion in macrophages co-cultured with tumor cells. When 
IKK    -targeted macrophages were co-cultured with ID8 tu-
mor cells, they showed increased tyrosine phosphorylation of 
Stat1 (pY-Stat1, Tyr701), which correlated with increased 
NOS2 expression (  Fig. 2 C  ). NOS2 has been directly im-
plicated in macrophage-mediated tumoricidal activity (  14  ), 
and several in vitro studies have demonstrated that NO do-
nors are cytotoxic and proapoptotic to tumor cells (  15, 16  ). 
We performed   111  In-release cytotoxicity assays in the pres-
ence of a selective NOS2 inhibitor, 1400W, and demon-
strated that inhibition of NOS2 rescues the cytotoxic activity 
of IKK    -targeted BMDMs or TAMs isolated from estab-
lished tumors         (  Fig. 2 D   and Fig. S1 D). These data suggest 
that IKK    -mediated suppression of Stat1 activation inhibits 
the M1 phenotype and tumoricidal activity of tumor-polar-
ized macrophages. 
  To investigate the in vivo implications of these obser-
vations, we adoptively transferred IKK    -targeted macro-
phages into mice bearing established ovarian tumors to test if 
  “  re-educating  ”   macrophages through IKK     inhibition could 
aff  ect tumor progression. ID8 ovarian cancer cells that ex-
pressed fi  refl  y luciferase were injected i.p. into mice. After 5 wk, 
these mice had malignant ascites and established tumors, with 
deposits throughout the peritoneum (  Figs. 3 A and 4 A  , 
and Fig. S2, which is available at http://www.jem.org/cgi/
content/full/jem.20080108/DC1) (  11  ).   We then adoptively 
transferred 5   ×   10  6   WT-, IKK           -, or IKK      DN  -expressing 
BMDMs or TAMs isolated from established tumors and in-
fected in vitro with the IKK      DN   adenovirus (TAM  DN  ). Tumor 
progression was assessed in situ by bioluminescence imaging 
on days 0, 7, and 14 after adoptive transfer (  Figs. 3 A and 4 A  , 
and Fig. S2). Transfer of IKK    -targeted BMDMs or TAMs 
into tumor-bearing mice led to a signifi  cant (P   <   0.01) de-
crease in tumor burden when compared with control macro-
phages (  Figs. 3 B and 4 B  , and Fig. S2). After 14 d, luciferase 
levels were still signifi   cantly lower in the IKK    -targeted 
group compared with the untreated or control groups (  Figs. 
3 B and 4 B  , and Fig. S2).   We next investigated whether the 
increase in NOS2 expression in IKK    -targeted macrophages 
was associated with enhanced tumoricidal activity in vivo. 
4 h after adoptive transfer of IKK    -targeted BMDMs or 
TAMs, there were signifi  cantly higher NO levels in the peri-
toneum compared with control groups (  Figs. 3 C and 4 C  , 
and Fig. S2; P   <   0.01); however, this was not sustained and 
NO levels were no diff  erent 24 h after transfer of macro-
phages, despite the sustained eff  ect on tumor growth (  Figs. 3 C 
and 4 C  , and Fig. S2). To analyze the TAM phenotype in vivo, 
we measured IL-10, IL-12, and TNF-     levels in ascitic fl  uid 
14 d after macrophage transfer (  Figs. 3 D and 4 D  , and Fig. S2). 
Mice receiving IKK    -targeted macrophages showed a signif-
icant change in cytokine production with a switch to an IL-10  low   
IL-12  high   and TNF-      low   profi  le (  Figs. 3 D and 4 D  , and Fig. S2; 
P   <   0.01). CD11b  +   ascitic macrophages from these mice ex-
pressed increased IL-12p40 and decreased arginase-1 mRNA 
    Figure 2.         IKK     maintains the alternative phenotype of tumor-
polarized macrophages.   WT, mock, IKK    DN   or  IKK   f/f  , and IKK          BMDMs 
were co-cultured with ID8 cells for 24 h. Supernatant was collected after 
24 h and analyzed for IL-10, IL-12p70, TNF-    , and NO production by 
ELISA. (A) Co-cultured WT macrophages express an immunosuppressive 
IL-10  high   IL-12p70 low   TNF-   high   profi  le. However, supernatant from co-
cultured IKK    -deleted macrophages show a signifi  cant decrease in IL-10 
and TNF-     (P   <   0.01;   t   test with Welch  ’  s correction) but increase in 
IL-12p70 (P   <   0.01;   t   test with Welch  ’  s correction). Data are represented 
as mean   ±   SD of   n   = 3. Representative data are shown from at least three 
independent experiments. (B) In parallel, total RNA was isolated for real-
time PCR analysis of IL-12p40 and arginase-1 in co-cultured macro-
phages. Targeting IKK     in macrophages switches their phenotype to an 
IL-12  high   arginase-1 low   NOS2 high   profi  le, consistent with an M1 phenotype. 
In    addition,  IKK   -targeted macrophages secrete signifi  cantly higher levels 
of NO, measured as nitrite by Griess assay (P   <   0.01; Mann-Whitney test). 
Data are represented as mean   ±   SD of   n   = 3. Representative data are 
shown from at least four independent experiments. (C) Macrophages were 
co-cultured with ID8 cells, and protein extracts were prepared at the indi-
cated time points for biochemical analysis. Expression of NF-    B p65, ser-
ine 536 phosphorylation of p65, IKK    , Stat1, tyrosine 701 phosphorylation 
of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell 
lysates using     -actin as a loading control. Representative data are shown 
from at least three independent experiments. (D) [  111  In]oxine release assay 
after co-culture of ID8 ovarian cancer cells with IKK    DN   or  IKK         BMDMs. 
IKK    -targeted macrophages promote increased cytotoxicity that was 
reversed by the addition of the selective NOS2 inhibitor 1400W. Data are 
represented as mean of   n   = 3. Representative data are shown from at 
least three independent experiments.     1264 NF-    B SIGNALING MAINTAINS THE PHENOTYPE OF TUMOR-ASSOCIATED MACROPHAGES | Hagemann et al.
which is available at http://www.jem.org/cgi/content/full/
jem.20080108/DC1) in ascites from mice adoptively trans-
ferred with IKK    -targeted macrophages.   We therefore rea-
soned that an IL-12  –  mediated increase in NK cells in the 
peritoneum may contribute to the tumoricidal eff  ect of tar-
geting IKK     in TAMs. To investigate this hypothesis, we 
treated mice with a neutralizing IL-12p40 antibody before 
adoptive transfer of macrophages. Neutralizing IL-12 in our 
model rescued the increased recruitment of NK cells in 
mice receiving IKK    -targeted macrophages and restored 
tumor growth to similar levels as in controls (  Fig. 5, A  –  C  , 
and Fig. S3). The p40 subunit of IL-12 is shared with the re-
lated proinfl  ammatory cytokine IL-23 (  17  ). To rule out a role 
for IL-23, we used a neutralizing antibody against IL-23p19. 
(  Figs. 3 D and 4 D  , and Fig. S2) and showed higher MHC 
class II surface expression compared with control macrophages 
(  Figs. 3 E and 4 E  , and Fig. S2). These data show that target-
ing IKK     activity in BMDMs prevents their polarization to 
an M2 phenotype by the tumor microenvironment in vivo. 
In addition, we show that inhibition of IKK     in TAMs iso-
lated from established tumors switches their phenotype from 
tumor-promoting M2 to antitumor M1. 
  Despite a sustained antitumor eff  ect upon transfer of 
IKK    -targeted macrophages in vivo, there was only a tran-
sient increase in NO production. This suggested that a dif-
ferent mechanism might be responsible for the long-term 
inhibition of tumor growth. Of particular interest was a sig-
nifi  cant (P   <   0.01) increase in NK cells (  Fig. 5 A   and Fig. S3, 
    Figure 3.         Adoptive transfer of IKK    -targeted BMDMs inhibits tumor growth in vivo.   (A) Representative bioluminescence imaging in vivo 14 d 
after adoptive transfer of BMDMs (  n   = 6; three independent experiments). ID8-Luc were injected i.p. into syngeneic mice and tumors were allowed to 
develop. After 35 d, WT, mock, and IKK    DN   BMDMs were adoptively transferred and peritoneal cells were collected after an additional 7 and 14 d. Biolumi-
nescence is presented as a pseudocolor scale: red, the highest photon fl  ux; blue, the lowest photon fl  ux. (B) Quantifi  cation of bioluminescence from pri-
mary tumors (  n   = 6 each) obtained on days 0, 7, and 14. Adoptively transferred IKK    DN   BMDMs  signifi  cantly reduced ID8 growth on day 14 (P   <   0.05;   t  
test with Welch  ’  s correction). (C) NO secretion into the peritoneal cavity. IKK    DN   BMDMs increased NO release 4 h after adoptive transfer (P   <   0.05;   t   test 
with Welch  ’  s correction). Data are represented as mean   ±   SD of   n   = 6. Representative data are shown from at least two independent experiments. 
(D) Cytokine profi  le in tumor ascites after 14 d. Ascites from mice treated with IKK    -targeted BMDMs contained signifi  cantly lower amounts of IL-10 and 
TNF-     but higher amounts of IL-12 (P   <   0.01; Mann-Whitney test). Total RNA was isolated from CD11b  +  -selected ascitic macrophages for real-time PCR 
analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression compared with WT macrophages (  n   =  6). 
(E) MHC class II expression in the ascitic CD11b  +   myeloid cell population measured by FACS (percentage of positive cells indicated). Representative histo-
grams are shown from   n   =  6.   JEM VOL. 205, June 9, 2008  1265
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mediator of NF-    B activation in our co-culture system. To 
investigate the role of IL-1R/MyD88 signaling in macrophage 
polarization in vivo, we adoptively transferred BMDMs defi  cient 
in MyD88, TLR2, TLR4, or IL-1R into ID8 tumor  –  bearing 
mice. Mice treated with IL-1R      /      or MyD88      /      macrophages 
had signifi  cantly less tumor burden after 14 d (S4A). In addition, 
ascitic fl  uid from mice treated with IL-1R      /      or MyD88      /      
macrophages contained lower levels of IL-10 but higher levels 
of IL-12p70 compared with control groups (S4B). A similar 
switch toward an M1 phenotype was observed in the resident 
ascitic CD11b  +   population with an IL-12p40  high   arginase-1  low   
expression profi  le (S4C). 
  In summary, these data show that inhibition of IKK     
activity specifi  cally in TAMs is able to reverse their tumor-
polarized phenotype and re-educate them to actively kill 
tumor cells by both direct tumoricidal activity through NO 
Neutralizing IL-23p19 had no eff  ect on tumor growth (  Fig. 5 C   
and Fig. S3). In further experiments, we recapitulated NK 
cell  –  mediated tumoricidal activity ex vivo using purifi  ed spleen 
NK cells. DX5  +   NK cells were isolated and treated with as-
citic fl  uid from the adoptive transfer experiments described 
above. When NK cells were stimulated with ascites from mice 
receiving IKK    -targeted macrophages, they showed a signif-
icant increase in tumoricidal activity (  Fig. 5 D   and Fig. S3). 
This increase in cytotoxicity was rescued with a neutralizing 
antibody to IL-12p40, whereas neutralizing IL-23p19 had an 
additive eff  ect (  Fig. 5 D   and Fig. S3). 
  The data described above show that IKK     signaling in 
macrophages maintains their alternative tumor-promoting 
phenotype. The experiments described in   Fig. 1   show that 
IL-1R/MyD88 signaling in macrophages is important in driving 
tumor cell invasion, suggesting that IL-1 may be the soluble 
    Figure 4.         Adoptive transfer of IKK    -targeted TAMs inhibits tumor growth in vivo.   (A) Representative bioluminescence imaging in vivo 14 d after 
adoptive transfer of TAMs isolated from established ID8 tumors (  n   = 6; three independent experiments). ID8-Luc were injected i.p. into syngeneic mice 
and tumors were allowed to develop. After 35 d, mock- and IKK    DN  -infected TAMs (TAM  mock ,  TAM DN  , respectively) were adoptively transferred and perito-
neal cells were collected after an additional 7 and 14 d. Bioluminescence is presented as a pseudocolor scale: red, the highest photon fl  ux; blue, the low-
est photon fl  ux. (B) Quantifi  cation of bioluminescence from primary tumors (  n   = 6 each) obtained on days 0, 7, and 14. Adoptive transfer of TAM  DN  
signifi  cantly reduced ID8 growth on day 14 (P   <   0.05;   t   test with Welch  ’  s correction). (C) NO secretion into the peritoneal cavity. Transfer of TAM  DN   signifi  -
cantly increased NO production 4 h after adoptive transfer (P   <   0.05;   t   test with Welch  ’  s correction). Data are represented as mean   ±   SD of   n   = 6. Repre-
sentative data are shown from at least two independent experiments. (D) Cytokine profi  le in tumor ascites after 14 d. Ascitic fl  uid after transfer of TAM  DN  
contained signifi  cantly lower amounts of IL-10 and TNF-     but higher amounts of IL-12 (P   <   0.01; Mann-Whitney test). Total RNA was isolated from 
CD11b  +  -selected TAMs for real-time PCR analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression 
compared with TAM  mock  -treated mice (  n   = 6). (E) MHC class II expression in the ascitic CD11b  +   TAMs measured by FACS (percentage of positive cells indi-
cated). Representative histograms are shown from   n   =  6.   1266 NF-    B SIGNALING MAINTAINS THE PHENOTYPE OF TUMOR-ASSOCIATED MACROPHAGES | Hagemann et al.
characterized by high expression of IL-10, TNF-    , and argi-
nase-1, but low NOS2, IL-12, and MHC II expression. There 
is a large macrophage population in many tumors, and our 
data suggest that we may be able to harness their intrinsic anti-
tumor potential to promote tumor regression. During the 
1990s there were clinical trials of in vitro  –  activated autolo-
gous macrophages, using either IFN-     alone or in combi-
nation with LPS; however, this approach had only limited 
success (  18, 19  ). We have shown convincingly that targeting 
IKK     in TAMs reverses their tumor-promoting activity and 
can drive tumor regression in vivo. These studies suggest that 
IKK     inhibitors could represent a powerful therapeutic tool 
in cancer therapy. Besides the direct eff  ects on antiapoptotic 
signaling in malignant cells, IKK     inhibition may also modify 
the infl  ammatory microenvironment to promote an antitumor 
immune response. 
  MATERIALS AND METHODS 
  Cell lines and reagents.     The mouse ovarian cancer cell line ID8 (provided 
by K. Roby, University of Kansas, Kansas City, KS) (  20  ) was cultured as 
described previously (  10  ). Lentiviral infection of ID8 cells with luciferase 
reporter construct was performed as described previously (  21  ). In vitro lucif-
erase activity was assayed in 0.5   ×   10  6   ID8 cells in triplicate and according 
to the manufacturer  ’  s instructions (Promega). ID8  –  macrophage co-cultures 
were performed as described previously (  22  ). 
  Generation of mouse macrophages.     Mouse macrophages were derived 
from the bone marrow of WT, TLR2, TLR4, MyD88, and IL-1R knock-
out C57BL/6 mice or IKK     fl  oxed mice (IKK      f/f  ) and cultured for 7 d in 
DMEM medium supplemented with 10 ng/ml recombinant mouse M-CSF 
(R  &  D Systems). TAMs were isolated from the peritoneal cavity of mice in 
which ID8 ovarian cancers had been growing i.p. for 10 wk. 
  Macrophage infection.     BMDMs or CD11b  +  -selected in vivo  –  polarized 
TAMs were infected with recombinant adenovirus expressing a dominant-
negative inhibitor of IKK     (IKK      DN  , TAM  DN  ). These viruses are E1/E3 
deleted, belong to the Ad5 serotype, and have been used in other studies (  23, 24  ). 
IKK      f/f   BMDMs were infected with recombinant adenovirus expressing Cre. 
IKK      f/f   BMDMs infected with Adv-GFP were used as a control. Infections 
were performed at day 4 of macrophage diff  erentiation in the presence of 
recombinant mouse M-CSF (R  &  D Systems). 
  Western blotting.     Immunoblotting was performed with NOS2 (Santa Cruz 
Biotechnology, Inc.),     -actin (Sigma-Aldrich), NF-    B p65, phospho  –  NF-    B 
p65 (Ser536), Stat1, phospho-Stat1 (Tyr701), IKK     and phospho-IKK     
(Ser181), and I    B     and phospho-I    B     (Ser32; all Cell Signaling Technology). 
  DNA-binding activity of transcription factor NF-    B p50/p65.     NF-    B 
activation was measured using the TransFactor assay (Millipore) (  11  ). 
  Adoptive transfer of macrophages into mice bearing established 
tumors.     8-wk-old C57BL/6 female mice (B  &  K Universal) were injected 
i.p. with 10  6   ID8-Luc cells, and tumors were allowed to establish for 35 d. 
5   ×   10  6   macrophages were transferred adoptively i.p. on day 35. Neutral-
izing antibodies against IL-12p40/70 (17.8; R  &  D Systems), IL-23p19 
(G23-8; eBioscience), or the respective control antibody were injected i.p. 
at 100   μ  g/mouse twice weekly. To assess tumor progression, luciferase 
activity was measured in cell lysates. All mice were maintained in the Bio-
logical Services Unit, Institute of Cancer and the CR-UK Clinical Centre, 
Barts and The London School of Medicine, and used according to estab-
lished institutional guidelines under the authority of a UK Home Offi   ce 
project license (Guidance on the Operation of Animals, Scientifi  c Procedures 
Act 1986). 
production and the promotion of NK cell  –  mediated antitumor 
immunity through IL-12. 
  The studies described above reveal a new role for IKK     
in cancer-related infl  ammation. We demonstrate a previously 
unknown function for IKK     in maintaining the alternative 
phenotype of TAMs and negative regulation of macrophage 
tumoricidal activity. In malignant disease, macrophages are 
recruited to the tumor from the circulation and become 
polarized to an alternative immunosuppressive phenotype, 
    Figure 5.         Increased IL-12  –  dependent NK cell recruitment.  (A)  Neu-
tralizing IL-12p40 but not IL-23p19 rescued the antitumor effect of adop-
tively transferred IKK    DN   BMDMs (P   <   0.01; Mann-Whitney test). Data are 
represented as mean   ±   SEM of   n   = 6. Representative data are shown from 
two independent experiments. (B) Representative bioluminescence image 
of the IL-12p40  –  neutralizing experiment (  n   = 6). (C) Adoptive transfer of 
IKK    DN   BMDMs increases NK cell recruitment in ID8 tumors (P   <   0.01; 
Mann-Whitney test). Data are represented as mean   ±   SD of   n   = 6. Repre-
sentative data are shown from two independent experiments. (D) Ex vivo 
NK cell cytotoxicity assay. Splenic DX5  +  -enriched NK cells were stimulated 
with ascites from tumor-bearing mice, which had either no treatment or 
were treated with adoptive transfer of mock or IKK    DN   BMDMs.  Ascites 
from mice treated by adoptive transfer of IKK    DN   BMDMs led to a signifi  -
cant increase in NK cell  –  mediated tumor cell cytotoxicity (P   <   0.01;   t   test 
with Welch  ’  s correction). The addition of a neutralizing antibody against 
IL-12p40 but not IL-23p19 or the respective control antibody rescued the 
increased tumoricidal effect. Data are represented as mean of   n   = 3. Rep-
resentative data are shown from three independent experiments.     JEM VOL. 205, June 9, 2008  1267
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  Bioluminescence imaging.     Tumor progression was assessed in situ by 
bioluminescent imaging as described previously (  21  ). 
  Flow cytometry.     The phenotype of transferred macrophages was assessed 
by FACS analysis on a FACScan fl  ow cytometer and analyzed using Cell-
quest software (Becton Dickinson). 
  Cytotoxicity assays.     For   111  In-release assay, a cytotoxicity assay was per-
formed for 24 h with macrophages. Radioactivity was measured by counting 
1 min in a      counter. For   51  Cr-release assays, NK cell cytotoxicity was de-
fi  ned as lysis of target cells after 4 h. Ascite samples from tumor-bearing mice 
treated with adoptive transfer of modifi  ed macrophages were concentrated 
under vacuum for 30 min at 37  °  C. In vitro stimulation with ascites was per-
formed by adding 10   μ  g/ml concentrated total ascites at the start of the 4-h 
cytotoxicity assay. Neutralizing antibodies against IL-12p40/70 (17.8; R  &  D 
Systems) or IL-23p19 (G23-8; eBioscience) or the respective control anti-
body were added to the release assay at 10   μ  g/ml. 
  The percentage of cytotoxic activity was calculated as the specifi  c release 
of radioactivity: % cytotoxicity = [(experimental isotope      spontaneous iso-
tope)/total isotope      spontaneous isotope)]   ×   100. 
  ELISA-based assays.     To determine caspase-3/7 activity (Promega), cyto-
kine levels in cell culture supernatant or ascite ELISAs (R  &  D Systems) were 
used according to the manufacturer  ’  s instructions. 
  Statistical analysis.     Experiments were performed in triplicate, and repre-
sentative data are shown. Results were tested for statistical signifi  cance using 
Student  ’  s   t   test with Welch  ’  s correction or the Mann-Whitney test with 
GraphPad Prism Version 4.0c software. 
  Online supplemental material.     Fig. S1 shows the results of the NF-    B 
activity assay, the in vitro profi  le for in vivo  –  generated TAMs under co-
culture. Fig. S2 summarizes the in vivo adoptive transfer of IKK         macro-
phages and their respective controls. Fig. S3 shows the eff  ect of neutralizing 
IL12p40 and IL-23p19, and NK cell data. Fig. S4 shows ex vivo analysis of 
tumor burden in mice adoptively transferred with macrophages from MyD88, 
TLR2, TLR4, and IL-1R knockout mice. The online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20080108/DC1. 
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